| 摘要 |
The present invention relates to compositions and methods relating to the characterization and function of PNR. Specifically, the present invention provides transgenic animals comprising disruptions in a PNR gene and methods of treating diseases conditions, such as schizophrenia. The present invention further relates to agents that modulate PNR and methods of screening for agents that modulate PNR for the treatment of diseases and conditions such as schizophrenia.
|
